The Quarterly Journal of Nuclear Medicine 1998 September;42(3)

  NEU­RO­PHAR­MA­COL­O­GY

The Quarterly Journal of Nuclear Medicine 1998 September;42(3):149-50

Introduction

Frost J. J.

PDF

ORIGINAL ARTICLES  NEU­RO­PHAR­MA­COL­O­GY

The Quarterly Journal of Nuclear Medicine 1998 September;42(3):151-7

What are we measuring with PET?

Morgan A. E., Brodie J. D.*, Dewey S. L.

Abstract PDF

ORIGINAL ARTICLES  NEU­RO­PHAR­MA­COL­O­GY

The Quarterly Journal of Nuclear Medicine 1998 September;42(3):158-65

Special issues in quantitation of brain receptors and related markers by emission computed tomography

Links J. M.

Abstract PDF

ORIGINAL ARTICLES  NEU­RO­PHAR­MA­COL­O­GY

The Quarterly Journal of Nuclear Medicine 1998 September;42(3):166-78

Neurochemical imaging of Alzheimer’s disease and other degenerative dementias

Frey K. A., Minoshima S., Kuhl D. E.

Abstract PDF

ORIGINAL ARTICLES  NEU­RO­PHAR­MA­COL­O­GY

The Quarterly Journal of Nuclear Medicine 1998 September;42(3):179-92

Functional imaging of neurotransmitter systems in movement disorders

Ilgin N.

Abstract PDF

ORIGINAL ARTICLES  NEU­RO­PHAR­MA­COL­O­GY

The Quarterly Journal of Nuclear Medicine 1998 September;42(3):193-8

Imaging neurochemistry of cerebrovascular disease with PET and SPECT

Hatazawa J., Shimosegawa E.

Abstract PDF

ORIGINAL ARTICLES  NEU­RO­PHAR­MA­COL­O­GY

The Quarterly Journal of Nuclear Medicine 1998 September;42(3):199-210

Neuropharmacological imaging in epilepsy with PET and SPECT

Henry T. R., Pennell P. B.

Abstract PDF

ORIGINAL ARTICLES  NEU­RO­PHAR­MA­COL­O­GY

The Quarterly Journal of Nuclear Medicine 1998 September;42(3):211-21

Imaging dopamine transmission in schizophrenia. A review and meta-analysis

Laruelle M.

Abstract PDF